Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report - MarketLine Company Profiles

Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report

Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report - MarketLine Company Profiles
Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report
Published Sep 30, 2017
52 pages — Published Sep 30, 2017
Price US$ 525.00  |  Buy this Report Now

About This Report

  
Abstract:

Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report

Summary

Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Key Highlights

Novo Nordisk (or 'the company') is a global healthcare company engaged in providing diabetes and obesity care products. The company also has a leadership position in haemophilia, growth hormone therapy and hormone replacement therapy. Novo Nordisk operates in Europe, North America, China, Japan, Korea and other regions of the world. It is headquartered in Bagsvaerd, Denmark.

Scope

- Detailed information on Novo Nordisk A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novo Nordisk A/S in the form of a SWOT analysis
- An in-depth view of the business model of Novo Nordisk A/S including a breakdown and examination of key business segments
- Intelligence on Novo Nordisk A/S's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novo Nordisk A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Novo Nordisk A/S and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novo Nordisk A/S as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novo Nordisk A/S's business structure, strategy and prospects.

  
Source:
Document ID
4360B8DC-7C22-4AEB-BB02-EE58548B8710
Industry
Ticker
DK=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Company Profiles—MarketLine Company Profiles – Company information, covering everything from history and personnel to competitors, products, and services. Selected profiles of the largest global corporations also include SWOT Analysis which uncovers the strengths, weaknesses, opportunities, and threats so you can make informed assessments within minutes.

About the Author


Cite this Report

  
MLA:
MarketLine Company Profiles. "Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report" Sep 30, 2017. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketLine-Company-Profiles/Novo-Nordisk-A-S-Strategy-SWOT-and-Corporate-Finance-Report-2123-90179>
  
APA:
MarketLine Company Profiles. (2017). Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report Sep 30, 2017. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketLine-Company-Profiles/Novo-Nordisk-A-S-Strategy-SWOT-and-Corporate-Finance-Report-2123-90179>
  
US$ 525.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Company Profiles from one place.